ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CD19 (+) B Cell Combined with Prognostic Nutritional Index Predicts the Clinical Outcomes of Patients with Gastric Cancer Who Underwent Surgery

Sun, Hao; Wang, Huibo; Pan, Hongming; Zuo, Yanjiao; Zhao, Ruihu; Huang, Rong; Xue, Yingwei; Song, Hongjiang*哈尔滨医科大学
Cancers2023-4-28DOI: 10.3390/cancers15092531
1被引5阅读
引用收藏
分享

摘要

Gastric cancer has a high degree of malignancy, and even with comprehensive surgical treatment, there is still a high probability of recurrence and metastasis. Finding accurate predictive biomarkers can screen high-risk patients and intervene in a timely manner, which is extremely important for prolonging patient survival. In addition, the value of lymphocyte subset detection in patients with gastric cancer who underwent surgery still needs further exploration. This study further explored the predictive ability of lymphocyte subsets on the prognosis of gastric cancer patients who underwent surgery on a larger sample size and explored the prognostic value of CD19 (+) B cell combined with the Prognostic Nutritional Index (PNI). The results showed that lymphocyte subsets were related to the clinical outcome, the combined index had a stronger prognostic predictive ability than single markers and other non-invasive biomarkers, and was a powerful predictive biomarker for gastric cancer patients who underwent surgery. @@@ 1) Background: The aim of this study was to explore the predictive ability of lymphocyte subsets for the prognosis of gastric cancer patients who underwent surgery and the prognostic value of CD19 (+) B cell combined with the Prognostic Nutritional Index (PNI). (2) Methods: This study involved 291 patients with gastric cancer who underwent surgery at our institution between January 2016 and December 2017. All patients had complete clinical data and peripheral lymphocyte subsets. Differences in clinical and pathological characteristics were examined using the Chi-square test or independent sample t-tests. The difference in survival was evaluated using Kaplan-Meier survival curves and the Log-rank test. Cox's regression analysis was performed to identify independent prognostic indicators, and nomograms were used to predict survival probabilities. (3) Results: Patients were categorized into three groups based on their CD19 (+) B cell and PNI levels, with 56 cases in group one, 190 cases in group two, and 45 cases in group three. Patients in group one had a shorter progression-free survival (PFS) (HR = 0.444, p < 0.001) and overall survival (OS) (HR = 0.435, p < 0.001). CD19 (+) B cell-PNI had the highest area under the curve (AUC) compared with other indicators, and it was also identified as an independent prognostic factor. Moreover, CD3 (+) T cell, CD3 (+) CD8 (+) T cell, and CD3 (+) CD16 (+) CD56 (+) NK T cell were all negatively correlated with the prognosis, while CD19 (+) B cell was positively associated with the prognosis. The C-index and 95% confidence interval (CI) of nomograms for PFS and OS were 0.772 (0.752-0.833) and 0.773 (0.752-0.835), respectively. (4) Conclusions: Lymphocyte subsets including CD3 (+) T cell, CD3 (+) CD8 (+) T cell, CD3 (+) CD16 (+) CD56 (+) NK T cell, and CD19 (+) B cell were related to the clinical outcomes of patients with gastric cancer who underwent surgery. Additionally, PNI combined with CD19 (+) B cell had higher prognostic value and could be used to identify patients with a high risk of metastasis and recurrence after surgery.

学科与关键词

关键词
gastric cancersurgeryperipheral lymphocyte subsetsprognostic nutritional indexprognostic factor
相关
加载中…
  • Lymphocyte subset is more suitable than systemic inflammatory response biomarker and immunoglobulin in constructing prognostic nomogram model for advanced gastric cancer
    Fang, Tianyi; Yin, Xin; Wang, Yufei; Zhang, Lei; Wang, Yimin; Zhang, Xinghai; Zhao, Xudong; Lin, Xuan; Xue, Yingwei*Heliyon, 2023, 9(3): e14669.被引 2
  • Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors
    Sun, Hao; Chen, Li; Huang, Rong; Pan, Hongming; Zuo, Yanjiao; Zhao, Ruihu; Xue, Yingwei; Song, Hongjiang*Frontiers in Nutrition, 2022, 9: 1038118.被引 9
  • Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery
    Du, Zhongze; Sun, Hao; Zhao, Ruihu; Deng, Guiming; Pan, Hongming; Zuo, Yanjiao; Huang, Rong; Xue, Yingwei; Song, Hongjiang*Frontiers in Oncology, 2023, 13: 1113428.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancers
发表日期
2023-04-28
卷期
第 15 卷, 第 9 期
页码
2531
DOI
10.3390/cancers15092531
成果收录
SCIE
资助标注
Clinical Research Foundation of Wu Jieping Medical Foundation [320.6750.2022-07-13]

作者

  • S

    Sun, Hao (第一作者)

    harbin med univ

  • W

    Wang, Huibo

    harbin med univ

查看全部 8 位作者收起作者
  • P

    Pan, Hongming

    harbin med univ

  • Z

    Zuo, Yanjiao

    harbin med univ

  • Z

    Zhao, Ruihu

    harbin med univ

  • H

    Huang, Rong

    harbin med univ

  • X

    Xue, Yingwei

    harbin med univ

  • S

    Song, Hongjiang (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417